Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
1.580
-0.010 (-0.63%)
At close: Oct 24, 2024, 4:00 PM
1.590
+0.010 (0.63%)
After-hours: Oct 24, 2024, 5:20 PM EDT
Akebia Therapeutics Market Cap
Akebia Therapeutics has a market cap or net worth of $332.26 million as of October 24, 2024. Its market cap has increased by 64.89% in one year.
Market Cap
332.26M
Enterprise Value
399.48M
1-Year Change
64.89%
Ranking
Category
Stock Price
$1.58
Market Cap Chart
Since March 20, 2014, Akebia Therapeutics's market cap has decreased from $488.10M to $332.26M, a decrease of -31.93%. That is a compound annual growth rate of -3.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2024 | 334.40M | 43.15% |
| Dec 29, 2023 | 233.60M | 120.17% |
| Dec 30, 2022 | 106.10M | -73.17% |
| Dec 31, 2021 | 395.40M | -2.30% |
| Dec 31, 2020 | 404.70M | -46.16% |
| Dec 31, 2019 | 751.70M | 138.26% |
| Dec 31, 2018 | 315.50M | -55.11% |
| Dec 29, 2017 | 702.90M | 76.17% |
| Dec 30, 2016 | 399.00M | 0.81% |
| Dec 31, 2015 | 395.80M | 67.15% |
| Dec 31, 2014 | 236.80M | -51.49% |
| Mar 20, 2014 | 488.10M | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nautilus Biotechnology | 337.36M |
| Jin Medical International | 335.01M |
| Amylyx Pharmaceuticals | 334.08M |
| Aurora Cannabis | 333.29M |
| Nano-X Imaging | 332.85M |
| XOMA Royalty | 330.28M |
| Aldeyra Therapeutics | 329.79M |
| Lexeo Therapeutics | 326.11M |